NAMS MENOPAUSE CERTIFICATION
EXAM 2024
210+ (Latest Syllabus 2026) Exam Questions | Verified Model Answers |
A+ Graded Bank
100% Guarantee Pass
📋 DOCUMENT OVERVIEW 212 Qs
This document, "NAMS Menopause Certification Exam 2024," covers specific topics related to
menopause, including the climacteric phase, perimenopause, STRAW staging, luteal out-of-phase
events, estrogen levels, and osteoporosis. It provides a comprehensive review of menopause concepts
through 212 questions with correct answers and detailed explanations, along with diagrams and images.
Students can use this document to study, review, and understand menopause-related concepts,
leveraging the provided rationales to reinforce their knowledge and prepare effectively for exams.
✓ Verified Answers ✓ Exam Ready ✓ Study Guide
Trusted by thousands of students and professionals worldwide
EXAM QUESTIONS
QUESTION 1
Climacteric phase
CORRECT ANSWER
The period of endrocrinologic, somatic, and transitory psychologic changes that occur around the time of
menopause.
RATIONALE: The term "Climacteric phase" accurately describes the period of endocrine, somatic, and transitory
psychological changes due to its etymological roots in Greek, where "klimakterikos" means "a ladder" or "a series of
stages," reflecting the progressive nature of these changes. This definition encompasses the combination of physical
and hormonal shifts that occur during menopause, thereby making it a comprehensive description of this life stage.
QUESTION 2
Perimenopause Menopause Transition, Early
List the STRAW Stage
What defines the phase?
Trusted by thousands of students and professionals worldwide Page 1 of 60
, CORRECT ANSWER
STRAW Stage: (Stage -2)
Persistent difference of 7 days or more in the length of consecutive cycles.
RATIONALE: The STRAW stage of -2 is defined by a persistent difference of 7 days or more in the length of consecutive
cycles, which indicates a significant deviation from the typical menstrual cycle length and is a characteristic feature of
the perimenopause transition. This stage reflects the early menopause transition where hormonal fluctuations start to
disrupt the menstrual cycle, leading to irregularities and changes in cycle length.
QUESTION 3
Perimenopause Menopause Transition, Late
List the STRAW Stage
What defines the phase?
CORRECT ANSWER
STRAW Stage: (Stage -1)
60 or more consecutive days of amenorrhea
RATIONALE: The STRAW Stage (Stage -1) "60 or more consecutive days of amenorrhea" is correct because it
represents the late perimenopause menopause transition stage, where women experience a significant decline in
estrogen levels, leading to prolonged periods of amenorrhea or cessation of menstrual cycles.
The STRAW (Segal's Stages of the Reproductive Age Women) classification system categorizes menopausal stages
based on duration of amenorrhea, with Stage -1 specifically indicating 60 or more days of consecutive amenorrhea,
marking the onset of postmenopausal status.
The stages are as follows:
- STRAW Stage 1: 2-7 day decrease in menstrual frequency
- STRAW Stage 2: 7-14 day decrease in menstrual frequency
- STRAW Stage 3: 14-28 day decrease in menstrual frequency
- STRAW Stage 4: 28-35 day decrease in menstrual frequency
- STRAW Stage
QUESTION 4
Luteal out of phase event (LOOP)
CORRECT ANSWER
Explains why some perimenopausal women have elevated estrogen level sometimes...In the early
menopause transition, elevated FSH levels are adequate to recruit a second follicle which results in a
follicular phase-like rise in estradiol secretion superimposed on the mid-to-late luteal phase of the
ongoing ovulatory cycle.
RATIONALE: The correct answer is accurate because the early menopause transition's unique hormonal dynamics allow
for a luteal phase out-of-phase event (LOOP) to occur when elevated FSH levels recruit a second follicle, resulting in an
unexpected follicular phase-like rise in estradiol secretion. This unexpected rise in estradiol superimposed on the
ongoing luteal phase disrupts the usual hormonal patterns, leading to the characteristic LOOP event observed in some
perimenopausal women.
Trusted by thousands of students and professionals worldwide Page 2 of 60
, QUESTION 5
Describe the E2 level during the life of a patient with obesity.
CORRECT ANSWER
They are also more likely to have lower premenopause/perimenopausal estradiol levels compared to
patients with average BMIs. However, the level is the highest in postmenopausal patients with obesity.
RATIONALE: In patients with obesity, lower estradiol levels are observed during premenopause and perimenopause due
to increased adipose tissue, which converts estradiol to weaker forms, thereby reducing its concentration. Conversely, in
postmenopausal patients with obesity, estradiol levels can be higher because the conversion of estradiol to weaker
forms is reduced, allowing for its accumulation in the body.
QUESTION 6
In comparison to other ethnicities, Chinese and Japanese women have ___ E2 levels?
CORRECT ANSWER
These ethnic groups have lower estradiol levels than white, black and hispanic women.
RATIONALE: This statement is correct because it specifies the comparison groups, implying that estradiol levels in
Chinese and Japanese women are being compared to those of white, black, and Hispanic women, not other ethnic
groups. The comparison to these specific ethnic groups is likely relevant because it is based on existing research or data
that has already established differences in estradiol levels among various populations.
QUESTION 7
STRAW Stage +2, describe the timeline as well as the predominant symptoms.
CORRECT ANSWER
Postmenopause, Late. (Remaining Lifespan) 5-8 years after FMP. Somatic aging predominates. Increased
genitourinary symptoms.
RATIONALE: The STRAW Stage +2 timeline refers to the postmenopause period, specifically the late stage, where
remaining lifespan is estimated to be 5-8 years after the Final Menstrual Period (FMP). Somatic aging predominates
during this stage, leading to increased genitourinary symptoms due to the decline in estrogen levels and the resulting
physiological changes in the body.
QUESTION 8
Stages +1a, +1b, +1c, describe the timeline as well as the supportive criteria and the symptoms.
CORRECT ANSWER
Postmenopause, Early. 2 years after FMP.
+1a/b (2yrs) FSH variable where as the AMH and InhB are low. The AFC are very low. VMS predominate.
1c (3-6yrs) FSH levels stabilize. The other measures continue as previous.
Trusted by thousands of students and professionals worldwide Page 3 of 60
, RATIONALE: This answer accurately describes the stages of postmenopause, specifically +1a, +1b, and +1c, by
outlining the timeline and supportive criteria for each stage, including hormone levels and symptoms such as VMS
(vasomotor symptoms). The key concepts highlighted in this answer, such as FSH levels stabilizing and AMH, InhB, and
AFC (antral follicle count) remaining low, demonstrate a clear understanding of the physiological changes that occur
during postmenopause.
QUESTION 9
Elevated FSH, LH
CORRECT ANSWER
Endocrine labs after menopause
RATIONALE: During menopause, the hypothalamic-pituitary-ovarian axis undergoes significant changes, typically
resulting in elevated FSH and LH levels as the pituitary gland responds to decreased estrogen production from the
ovaries by increasing production of these gonadotropins. This physiological response is a key feature of menopause,
making elevated FSH and LH a relevant indicator for endocrine labs after menopause.
QUESTION 10
AMH, Inhibin B
CORRECT ANSWER
These hormones work during reproductive years to not deplete follicle pool too quickly.
RATIONALE: Anti-mullerian hormone (AMH) and inhibin B work together to regulate the growth and recruitment of
follicles in the ovaries, thereby maintaining a stable follicle pool during reproductive years. This prevents the depletion
of follicles too quickly, which is essential for maintaining healthy ovarian function and ensuring regular menstrual cycles.
QUESTION 11
Describe the phases during the early menopause transition and what happens with PMS symptoms
CORRECT ANSWER
Menstrual cycle shortens. Due to unrestrained FSH, follicular phase compresses. More premenstrual
symptoms due to the longer luteal phase. Cycle irregularity and skipped cycles because of ovulatory
failure and increased atresia.
RATIONALE: During the early menopause transition, the ovaries produce higher levels of FSH, leading to a compressed
follicular phase and a prolonged luteal phase, which contributes to increased premenstrual symptoms. This hormonal
imbalance affects ovulation and follicular development, resulting in irregular cycles and skipped periods due to ovulatory
failure and increased atresia of follicles.
QUESTION 12
How to respond if a patient requests FSH lab?
CORRECT ANSWER
Trusted by thousands of students and professionals worldwide Page 4 of 60
EXAM 2024
210+ (Latest Syllabus 2026) Exam Questions | Verified Model Answers |
A+ Graded Bank
100% Guarantee Pass
📋 DOCUMENT OVERVIEW 212 Qs
This document, "NAMS Menopause Certification Exam 2024," covers specific topics related to
menopause, including the climacteric phase, perimenopause, STRAW staging, luteal out-of-phase
events, estrogen levels, and osteoporosis. It provides a comprehensive review of menopause concepts
through 212 questions with correct answers and detailed explanations, along with diagrams and images.
Students can use this document to study, review, and understand menopause-related concepts,
leveraging the provided rationales to reinforce their knowledge and prepare effectively for exams.
✓ Verified Answers ✓ Exam Ready ✓ Study Guide
Trusted by thousands of students and professionals worldwide
EXAM QUESTIONS
QUESTION 1
Climacteric phase
CORRECT ANSWER
The period of endrocrinologic, somatic, and transitory psychologic changes that occur around the time of
menopause.
RATIONALE: The term "Climacteric phase" accurately describes the period of endocrine, somatic, and transitory
psychological changes due to its etymological roots in Greek, where "klimakterikos" means "a ladder" or "a series of
stages," reflecting the progressive nature of these changes. This definition encompasses the combination of physical
and hormonal shifts that occur during menopause, thereby making it a comprehensive description of this life stage.
QUESTION 2
Perimenopause Menopause Transition, Early
List the STRAW Stage
What defines the phase?
Trusted by thousands of students and professionals worldwide Page 1 of 60
, CORRECT ANSWER
STRAW Stage: (Stage -2)
Persistent difference of 7 days or more in the length of consecutive cycles.
RATIONALE: The STRAW stage of -2 is defined by a persistent difference of 7 days or more in the length of consecutive
cycles, which indicates a significant deviation from the typical menstrual cycle length and is a characteristic feature of
the perimenopause transition. This stage reflects the early menopause transition where hormonal fluctuations start to
disrupt the menstrual cycle, leading to irregularities and changes in cycle length.
QUESTION 3
Perimenopause Menopause Transition, Late
List the STRAW Stage
What defines the phase?
CORRECT ANSWER
STRAW Stage: (Stage -1)
60 or more consecutive days of amenorrhea
RATIONALE: The STRAW Stage (Stage -1) "60 or more consecutive days of amenorrhea" is correct because it
represents the late perimenopause menopause transition stage, where women experience a significant decline in
estrogen levels, leading to prolonged periods of amenorrhea or cessation of menstrual cycles.
The STRAW (Segal's Stages of the Reproductive Age Women) classification system categorizes menopausal stages
based on duration of amenorrhea, with Stage -1 specifically indicating 60 or more days of consecutive amenorrhea,
marking the onset of postmenopausal status.
The stages are as follows:
- STRAW Stage 1: 2-7 day decrease in menstrual frequency
- STRAW Stage 2: 7-14 day decrease in menstrual frequency
- STRAW Stage 3: 14-28 day decrease in menstrual frequency
- STRAW Stage 4: 28-35 day decrease in menstrual frequency
- STRAW Stage
QUESTION 4
Luteal out of phase event (LOOP)
CORRECT ANSWER
Explains why some perimenopausal women have elevated estrogen level sometimes...In the early
menopause transition, elevated FSH levels are adequate to recruit a second follicle which results in a
follicular phase-like rise in estradiol secretion superimposed on the mid-to-late luteal phase of the
ongoing ovulatory cycle.
RATIONALE: The correct answer is accurate because the early menopause transition's unique hormonal dynamics allow
for a luteal phase out-of-phase event (LOOP) to occur when elevated FSH levels recruit a second follicle, resulting in an
unexpected follicular phase-like rise in estradiol secretion. This unexpected rise in estradiol superimposed on the
ongoing luteal phase disrupts the usual hormonal patterns, leading to the characteristic LOOP event observed in some
perimenopausal women.
Trusted by thousands of students and professionals worldwide Page 2 of 60
, QUESTION 5
Describe the E2 level during the life of a patient with obesity.
CORRECT ANSWER
They are also more likely to have lower premenopause/perimenopausal estradiol levels compared to
patients with average BMIs. However, the level is the highest in postmenopausal patients with obesity.
RATIONALE: In patients with obesity, lower estradiol levels are observed during premenopause and perimenopause due
to increased adipose tissue, which converts estradiol to weaker forms, thereby reducing its concentration. Conversely, in
postmenopausal patients with obesity, estradiol levels can be higher because the conversion of estradiol to weaker
forms is reduced, allowing for its accumulation in the body.
QUESTION 6
In comparison to other ethnicities, Chinese and Japanese women have ___ E2 levels?
CORRECT ANSWER
These ethnic groups have lower estradiol levels than white, black and hispanic women.
RATIONALE: This statement is correct because it specifies the comparison groups, implying that estradiol levels in
Chinese and Japanese women are being compared to those of white, black, and Hispanic women, not other ethnic
groups. The comparison to these specific ethnic groups is likely relevant because it is based on existing research or data
that has already established differences in estradiol levels among various populations.
QUESTION 7
STRAW Stage +2, describe the timeline as well as the predominant symptoms.
CORRECT ANSWER
Postmenopause, Late. (Remaining Lifespan) 5-8 years after FMP. Somatic aging predominates. Increased
genitourinary symptoms.
RATIONALE: The STRAW Stage +2 timeline refers to the postmenopause period, specifically the late stage, where
remaining lifespan is estimated to be 5-8 years after the Final Menstrual Period (FMP). Somatic aging predominates
during this stage, leading to increased genitourinary symptoms due to the decline in estrogen levels and the resulting
physiological changes in the body.
QUESTION 8
Stages +1a, +1b, +1c, describe the timeline as well as the supportive criteria and the symptoms.
CORRECT ANSWER
Postmenopause, Early. 2 years after FMP.
+1a/b (2yrs) FSH variable where as the AMH and InhB are low. The AFC are very low. VMS predominate.
1c (3-6yrs) FSH levels stabilize. The other measures continue as previous.
Trusted by thousands of students and professionals worldwide Page 3 of 60
, RATIONALE: This answer accurately describes the stages of postmenopause, specifically +1a, +1b, and +1c, by
outlining the timeline and supportive criteria for each stage, including hormone levels and symptoms such as VMS
(vasomotor symptoms). The key concepts highlighted in this answer, such as FSH levels stabilizing and AMH, InhB, and
AFC (antral follicle count) remaining low, demonstrate a clear understanding of the physiological changes that occur
during postmenopause.
QUESTION 9
Elevated FSH, LH
CORRECT ANSWER
Endocrine labs after menopause
RATIONALE: During menopause, the hypothalamic-pituitary-ovarian axis undergoes significant changes, typically
resulting in elevated FSH and LH levels as the pituitary gland responds to decreased estrogen production from the
ovaries by increasing production of these gonadotropins. This physiological response is a key feature of menopause,
making elevated FSH and LH a relevant indicator for endocrine labs after menopause.
QUESTION 10
AMH, Inhibin B
CORRECT ANSWER
These hormones work during reproductive years to not deplete follicle pool too quickly.
RATIONALE: Anti-mullerian hormone (AMH) and inhibin B work together to regulate the growth and recruitment of
follicles in the ovaries, thereby maintaining a stable follicle pool during reproductive years. This prevents the depletion
of follicles too quickly, which is essential for maintaining healthy ovarian function and ensuring regular menstrual cycles.
QUESTION 11
Describe the phases during the early menopause transition and what happens with PMS symptoms
CORRECT ANSWER
Menstrual cycle shortens. Due to unrestrained FSH, follicular phase compresses. More premenstrual
symptoms due to the longer luteal phase. Cycle irregularity and skipped cycles because of ovulatory
failure and increased atresia.
RATIONALE: During the early menopause transition, the ovaries produce higher levels of FSH, leading to a compressed
follicular phase and a prolonged luteal phase, which contributes to increased premenstrual symptoms. This hormonal
imbalance affects ovulation and follicular development, resulting in irregular cycles and skipped periods due to ovulatory
failure and increased atresia of follicles.
QUESTION 12
How to respond if a patient requests FSH lab?
CORRECT ANSWER
Trusted by thousands of students and professionals worldwide Page 4 of 60
